Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (DFPH) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Oncology Institute (DFPH) over the last 5 years, with Q3 2025 value amounting to 0.43%.

  • Oncology Institute's Return on Capital Employed rose 500.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.43% for FY2024, which is 500.0% down from last year.
  • Oncology Institute's Return on Capital Employed amounted to 0.43% in Q3 2025, which was up 500.0% from 0.48% recorded in Q2 2025.
  • Oncology Institute's Return on Capital Employed's 5-year high stood at 0.05% during Q2 2021, with a 5-year trough of 0.49% in Q2 2022.
  • Its 5-year average for Return on Capital Employed is 0.37%, with a median of 0.43% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -4500bps in 2022, then skyrocketed by 600bps in 2024.
  • Oncology Institute's Return on Capital Employed (Quarter) stood at 0.25% in 2021, then tumbled by -38bps to 0.34% in 2022, then decreased by -28bps to 0.43% in 2023, then fell by -13bps to 0.49% in 2024, then grew by 12bps to 0.43% in 2025.
  • Its Return on Capital Employed was 0.43% in Q3 2025, compared to 0.48% in Q2 2025 and 0.48% in Q1 2025.